ANTHEM-TIMI 32

ANTHEM-TIMI 32 assessed the efficacy and safety of anticoagulation with rNAPc2 in non-ST segment elevation acute coronary syndrome patients managed with an early invasive strategy in 203 patients with nSTE-ACS undergoing early catheterization.

ANTHEM_Page_1

MAIN RESULTS:
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial
ANTHEM-TIMI 32
J Am Coll Cardiol. 2007 Jun 26;49(25):2398-407.

PRESENTATIONS

ANTHEM Main Results (AHA 05)
TIMI 32 Slides

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close